The persistent lack of diversity in clinical trial recruitment has come to the fore as one of the most salient challenges to trial success. Now we are seeing research, policy and industry commitment combine to build unprecedented momentum for impactful change — as evidenced by the April 2022 draft guidance issued by the US Food and Drug Administration (FDA), shortly followed by the National Academies of Sciences, Engineering and Medicine’s publication of a consensus study report, Improving Representation in Clinical Trials and Research: Building Research Equity for Women and Underrepresented Groups.
With more than 2000 industry CEOs joining the CEO Action for Diversity & Inclusion Pledge, diversity in clinical trial recruitment has emerged as both a business and human priority.
Being intentional about diversity is important not only because of the recent FDA guidance, but because greater diversity in clinical trials has the potential to yield long-term value, by enabling a more accurate understanding and demonstration of efficacy, safety and indication-specific patient populations — insights that can be used to optimize launch and marketing strategy.
This webinar will explore approaches for incorporating diversity-centric strategies into clinical development and how tech-enabled, human-centered solutions can enable companies to act on FDA guidelines, industry commitments and the ethical responsibility to communities for diverse and equitable clinical trials.
Register to learn more about amplifying diversity in clinical trial recruitment using tech-enabled solutions.
Monika Hirschbichler, VP, Program Strategy, Kinetic™, Syneos Health
Monika Hirschbichler, VP of Program Strategy at Syneos Health, is a seasoned business strategist with 20+ years of expertise, particularly in entrepreneurial ventures across niche audiences and domains. In her current role, which focuses on improving diversity and inclusion in clinical trial enrollment, Monika is incisively examining clinical trial recruitment and best practices. Her goal is to evolve the industry’s approach to health outcomes by empowering better trial data through representative recruitment and retention.
Brooke Belk, VP Omnichannel Strategy, Syneos Health
Brooke Baker Belk is an omnichannel marketing specialist with 10+ years of expertise in niche audience engagement and marketing strategy innovation. In her career with Syneos Health, Brooke has turned that experience toward engaging healthcare professionals and working within their relationships with their patients, to elevate awareness of clinical trials and support optimized trial enrollment.
Kasey Boynton, Sr. Director, Business Transformation, Syneos Health
Kasey Boynton brings over 15 years’ combined experience in the development and implementation of global clinical programs within CROs, academia and biotech companies. In her role as Sr. Director of Business Transformation, Kasey oversees diverse cross-functional strategic business initiatives, Go-to Market strategy, or special projects from development through successful execution as directed by executive leadership.
She has expertise in study development and demonstrating product value: encompassing aspects such as, clinical safety and efficacy, market access and scientific strategy, evidence generation, and cost-effectiveness. Her academic credentials include an MBA (University of Illinois- Chicago) and MPH from Johns Hopkins University.
Kasey co-leads the Syneos Health Black Employee Resource Group with whom she is building a culture of inclusivity, representation and belonging across the organization. Importantly, Kasey is also a key leader in Syneos Health’s work with patient diversity in clinical trials.
Nick Kenny, Chief Scientific Officer, Syneos Health
With over 21 years of experience in clinical development and consulting, Nick has been with Syenos Health since 2006. He grew and led the Oncology team until moving to the CSO role in 2018 where he now oversees the Medical Team for Syneos Health; the Consortia Models for Rare Diseases, Cell and Gene Therapy, Patient Voice etc.; leads Patient Diversity in Clinical Trials initiatives and is an executive leader on the Company’s Diversity, Equity & Inclusion (DE&I) Council.
Who Should Attend?
This webinar would be of interest to life sciences executives involved in:
- Regulatory Affairs
- Pharmacovigilance & Patient Safety
- Quality Assurance
- Clinical Operations
- Patient Advocacy & Engagement
- Diversity, Equity and Inclusion (DE&I)
- Business Development
- Product/Portfolio Strategy & Planning
- Medical Affairs
- Marketing & Communications
- Market Access & HEOR
What You Will Learn
- Learn how diversity derived insights can be used to optimize launch and marketing strategy
- Understand the key role that trial sites and healthcare professionals (HCPs) can play in diverse and equitable trial recruitment
- View case studies underscoring how tech-enabled solutions can amplify recruitment efforts and drive greater clinical trial diversity
Syneos Health® (Nasdaq: SYNH) is the only fully integrated biopharmaceutical solutions organization purpose-built to accelerate customer success. We lead with a product development mindset, strategically blending clinical development, medical affairs, and commercial capabilities to address modern market realities.
Together we share insights, use the latest technologies, and apply advanced business practices to speed our customers’ delivery of important therapies to patients. We support a diverse, equitable and inclusive culture.